Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2015 3
2016 15
2017 13
2018 19
2019 14
2020 30
2021 13
2022 14
2023 18
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study.
Chiba K, Okazaki N, Kurogi A, Watanabe T, Mori A, Suzuki N, Adachi K, Era M, Yokota K, Inoue T, Yabe Y, Furukawa K, Kondo C, Tsuda K, Ota S, Isobe Y, Miyazaki S, Morimoto S, Sato S, Nakashima S, Tashiro S, Yonekura A, Tomita M, Osaki M. Chiba K, et al. Among authors: sato s. Bone. 2022 Jul;160:116416. doi: 10.1016/j.bone.2022.116416. Epub 2022 Apr 6. Bone. 2022. PMID: 35398293 Free article. Clinical Trial.
Inhibition of bone erosion, determined by high-resolution peripheral quantitative computed tomography (HR-pQCT), in rheumatoid arthritis patients receiving a conventional synthetic disease-modifying anti-rheumatic drug (csDMARD) plus denosumab vs csDMARD therapy alone: an open-label, randomized, parallel-group study.
Iwamoto N, Chiba K, Sato S, Shiraishi K, Watanabe K, Oki N, Okada A, Koga T, Kawashiri SY, Tamai M, Hosogaya N, Furuyama M, Kobayashi M, Saito K, Okubo N, Uetani M, Osaki M, Kawakami A. Iwamoto N, et al. Among authors: sato s. Arthritis Res Ther. 2022 Dec 7;24(1):264. doi: 10.1186/s13075-022-02957-w. Arthritis Res Ther. 2022. PMID: 36476479 Free PMC article. Clinical Trial.
A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever.
Koga T, Sato S, Hagimori N, Yamamoto H, Ishimura M, Yasumi T, Kirino Y, Ikeda K, Yachie A, Migita K, Kishida D, Atsumi T, Kawakami A. Koga T, et al. Among authors: sato s. Clin Exp Rheumatol. 2022 Sep;40(8):1535-1542. doi: 10.55563/clinexprheumatol/fgx9vv. Epub 2022 Sep 14. Clin Exp Rheumatol. 2022. PMID: 36106542 Free article. Clinical Trial.
The clinical advantage of nasal high-flow in respiratory management during procedural sedation: A scoping review on the application of nasal high-flow during dental procedures with sedation.
Kurata S, Sanuki T, Higuchi H, Miyawaki T, Watanabe S, Maeda S, Sato S, Pinkham M, Tatkov S, Ayuse T. Kurata S, et al. Among authors: sato s. Jpn Dent Sci Rev. 2022 Nov;58:179-182. doi: 10.1016/j.jdsr.2022.05.003. Epub 2022 Jun 4. Jpn Dent Sci Rev. 2022. PMID: 35677939 Free PMC article. Review.
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Horiuchi Y, Matsue Y, Nogi K, Onitsuka K, Okumura T, Hoshino M, Shibata T, Nitta D, Yoshida K, Sato S, Damman K, Voors AA, Kitai T. Horiuchi Y, et al. Among authors: sato s. Am Heart J. 2023 Mar;257:85-92. doi: 10.1016/j.ahj.2022.12.005. Epub 2022 Dec 8. Am Heart J. 2023. PMID: 36503007 Clinical Trial.
133 results